Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2026 233.98M
June 30, 2026 270.96M
March 31, 2026 304.00M
December 31, 2025 339.77M
September 30, 2025 378.58M
Date Value
June 30, 2025 408.74M
March 31, 2025 445.61M
December 31, 2024 469.85M
September 30, 2024 220.56M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.387B
Alnylam Pharmaceuticals, Inc. 3.604B
Anika Therapeutics, Inc. 137.58M
Savara, Inc. 107.85M
Arrowhead Pharmaceuticals, Inc. 50.31M

Shareholders Equity (Quarterly) Related Metrics